29 studies found for:    Open Studies | "Gout"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
2 Recruiting Colchicine Or Naproxen Treatment for ACute gouT
Condition: Gout
Interventions: Drug: Low-dose colchicine;   Drug: Naproxen
3 Recruiting DECT Study in Allopurinol-Treated Gout Patients
Condition: Gout
Intervention: Procedure: DECT scan
4 Recruiting Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
Conditions: Gout;   Hyperuricemia
Interventions: Drug: URC102 0.25mg;   Drug: URC102 0.5mg;   Drug: URC102 1.0mg;   Drug: URC102 2.0mg;   Drug: placebo
5 Recruiting The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Syndrome;   Endothelial Dysfunction;   Hyperuricemia;   Gout;   Metabolic Syndrome
Intervention:
6 Recruiting Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
Condition: Gout
Interventions: Drug: RDEA3170 2.5 mg;   Drug: allopurinol 300 mg
7 Recruiting Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout
Condition: Gout
Interventions: Drug: Bucillamine;   Drug: Colchicine
8 Recruiting Intensive Urate Lowering Therapy With Febuxostat in Comparison With Allopurinol on Cardiovascular Risk in Patients With Gout
Condition: Gout
Interventions: Drug: Febuxostat 80/120mg/day;   Drug: Allopurinol 100 up to 600mg/day;   Drug: Colchicine;   Drug: Naproxen;   Drug: Omeprazole
9 Recruiting Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Condition: Chronic Gout
Intervention: Biological: pegloticase
10 Recruiting A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: AC-201;   Drug: Febuxostat
11 Recruiting Elastography as Gouty Arthropathy Outcome (EGO)
Condition: Gout
Intervention:
12 Recruiting Genetics of Hyperuricemia Therapy in Hmong
Condition: Hyperuricemia, Gout
Intervention: Drug: Allopurinol
13 Recruiting Rheumatology Informatics System for Effectiveness
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Gout
Intervention:
14 Recruiting Impact of Unapproved Drug Initiative on Colchicine Use
Condition: Gout
Intervention:
15 Recruiting Purine Metabolism Enzyme SNP to Uric Acid Production
Conditions: Gout;   Hyperuricemia
Intervention:
16 Recruiting Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Condition: Gouty Arthritis
Interventions: Drug: Canakinumab, ACZ885;   Drug: Triamcinolone acetonide
17 Recruiting Optimal Administration of Allopurinol in Dialysis Patients
Conditions: Gout;   Renal Insufficiency
Intervention: Drug: Allopurinol
18 Recruiting Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels
Condition: Gout
Intervention: Biological: SEL-037 (pegsiticase)
19 Not yet recruiting Pharmacogenetics of SGLT2 Inhibitors
Conditions: Diabetes Mellitus;   Gout;   Hyperuricemia
Intervention: Drug: Canagliflozin
20 Not yet recruiting Prospective Analgesic Compound Efficacy (PACE) Study
Conditions: Arthritis;   Tendonitis;   Gout;   Radiculopathy;   Muscle Spasms;   Synovitis;   Migraine;   Headache
Interventions: Drug: baclofen 2%;   Drug: Bupivacaine hydrochloride 1%;   Drug: Cyclobenzaprine hydrochloride 2%;   Drug: Diclofenac Sodium 3%;   Drug: Flurbiprofen 10%;   Drug: Gabapentin 6%;   Drug: Ketamine 10%;   Drug: Lidocaine 2%;   Drug: Prilocaine 2.5%;   Drug: Meloxicam 0.09%;   Drug: Sumatriptan 5%;   Drug: Tizanidine 0.1%;   Drug: Topiramate 2.5%;   Drug: Capsaicin, USP 0.0375%;   Drug: Menthol, NF 5.00 %

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years